These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 12815736)

  • 1. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia.
    Inada T; Nakamura A; Iijima Y
    Am J Med Genet B Neuropsychiatr Genet; 2003 Jul; 120B(1):35-9. PubMed ID: 12815736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
    Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
    Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catechol-O-methyltransferase val108/158met genotype and response to antipsychotic medication in schizophrenia.
    Illi A; Kampman O; Hänninen K; Anttila S; Mattila KM; Katila H; Rontu R; Hurme M; Lehtimäki T; Leinonen E
    Hum Psychopharmacol; 2007 Jun; 22(4):211-5. PubMed ID: 17526059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
    Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis.
    Herken H; Erdal ME
    Psychiatr Genet; 2001 Jun; 11(2):105-9. PubMed ID: 11525417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.
    Gupta M; Bhatnagar P; Grover S; Kaur H; Baghel R; Bhasin Y; Chauhan C; Verma B; Manduva V; Mukherjee O; Purushottam M; Sharma A; Jain S; Brahmachari SK; Kukreti R
    Pharmacogenomics; 2009 Mar; 10(3):385-97. PubMed ID: 19290789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between angiotensin-converting enzyme and catechol-O-methyltransferase genotypes in schizophrenics with poor response to conventional neuroleptics.
    Illi A; Kampman O; Anttila S; Roivas M; Mattila KM; Lehtimäki T; Leinonen E
    Eur Neuropsychopharmacol; 2003 May; 13(3):147-51. PubMed ID: 12729939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase and monoamine oxidase A genotypes and drug response to conventional neuroleptics in schizophrenia.
    Illi A; Mattila KM; Kampman O; Anttila S; Roivas M; Lehtimäki T; Leinonen E
    J Clin Psychopharmacol; 2003 Oct; 23(5):429-34. PubMed ID: 14520117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia.
    Park TW; Yoon KS; Kim JH; Park WY; Hirvonen A; Kang D
    Eur Neuropsychopharmacol; 2002 Aug; 12(4):299-303. PubMed ID: 12126868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY; Yeh YW; Kuo SC; Ho PS; Liang CS; Yen CH; Lu RB; Huang SY
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics.
    Ohmori O; Shinkai T; Kojima H; Terao T; Suzuki T; Mita T; Abe K
    Neurosci Lett; 1998 Feb; 243(1-3):109-12. PubMed ID: 9535125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.
    Taheri N; Pirboveiri R; Sayyah M; Bijanzadeh M; Ghandil P
    BMC Psychiatry; 2023 Oct; 23(1):781. PubMed ID: 37880658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of dopamine degradation enzyme (COMT and MAO) genes and tardive dyskinesia in patients with schizophrenia.
    Matsumoto C; Shinkai T; Hori H; Ohmori O; Nakamura J
    Psychiatry Res; 2004 Jun; 127(1-2):1-7. PubMed ID: 15261699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association study between the rs165599 catechol-O-methyltransferase genetic polymorphism and schizophrenia in a Brazilian sample.
    Cordeiro Q; Silva RT; Vallada H
    Arq Neuropsiquiatr; 2012 Dec; 70(12):913-6. PubMed ID: 23295417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.